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Type-C  RNA  retroviruses  are  present  in  a  wide  variety  of mammalian  species. 
These viruses can be classified  as endogenous or exogenous depending upon whether 
or not the complete virus genome is present within the germline of its species of origin. 
Although exogenous type-C viruses have often been shown to cause neoplastic diseases, 
much less is known about the oncogenic potential of endogenous viruses  (1). There is 
also little understanding, as yet, of the mechanisms  by which  type-C  viruses  induce 
leukemia in the susceptible host. 
We  reasoned  that  the  generation  of recombinants  between  an  oncogenic  mouse 
type-C  virus  and  an  endogenous  virus  without  demonstrable  malignant  potential 
could  provide  an  important  genetic  approach  for  analysis  of viral  gene(s)  directly 
involved  in  leukemogenesis.  In  this report,  we  describe  the  development  of a  tissue 
culture  system  that  has  made  possible  the reproducible  generation  of recombinant 
viruses. By genetic analysis of the recombinants obtained, regions of the viral genome 
involved in two distinct host restrictions to virus expression have been mapped. 
Materials and Methods 
Cell  Culture.  Cells  were  grown  in  Dulbecco's  modification  of Eagle's  minimum  essential 
medium supplemented with  10% calf serum (Colorado Serum Co., Denver, Colo.) in 60- ×  15- 
mm plastic Petri dishes  (Falcon Labware,  Div. of Becton, Dickinson,  & Co., Oxnard,  Calif.). 
The cells used  included clonal lines of continuous  mouse cells BALB/3T3 and  NIH/3T3  (2), 
and  a  normal  rat  kidney  (NRK) l  line  (3).  Other  mouse cell lines were derived from embryo 
cultures of a  wild mouse  (WM-C)  from a  colony maintained  by M.  Collins, Microbiological 
Associates, Bethesda,  Md, and  from the Fv-1 congenic Sim and  SimR strains  (4)  provided by 
A. Axelrad, University of Toronto, Toronto, Canada.  Embryo cultures of CBA, C3H, C57BL, 
and  C57BL/10  (5)  were also utilized. The human  tumor, A673  (6),  canine sarcoma,  D17  (7), 
and the mink, MvlLu (ATCC), cell lines have also been reported. 
Viruses.  A  clonal  isolate of Rauscher-murine  leukemia virus  (MuLV)  and  a  temperature- 
sensitive  (ts)  mutant  of this  virus,  ts  25,  have  been  described  (8).  An  inducible  xenotropic 
endogenous virus, BALB:virus-2, was originally isolated after 5-iodo-2'-deoxyuridine induction 
of BALB/c embryo cells in tissue culture  (9).  The virus was cloned by two cycles of end point 
dilution in A673 cells before use in these studies. 
Virus Assays.  Infection of cells was  performed  according  to previously published  methods 
* Supported in part by U. S. Public Health Service Contract N01-CP-61024  from the National Cancer 
Institute. 
1  Abbreviations used in  this paper: KiMuLV,  Kirsten  murine  leukemia  virus;  MuLV,  murine  leukemia 
virus(es);  NRK,  normal  rat  kidney:  PIU, polymerase-inducing units;  rec,  recombinant;  ts, temperature 
sensitive; WM-C, mouse cell line derived from embryo cultures of a wild mouse. 
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(9). Type-C virus synthesis by infected cultures was measured by an assay for virion-associated 
reverse-transcriptase activity in tissue  culture fluids (10). Neutralization tests  were performed 
by the focus reduction method using MuLV pseudotypes of KiMSV (9). 
Typzng Radioimmunoassays for MuL V Proteins.  The isolation of the p 15, p 12, p30, and gp70 
structural proteins of Rauscher-MuLV and BALB:virus-2 as well  as the reverse transcriptase 
and the gag gene-coded pl0 proteins of Rauscher-MuLV have been described in detail (11-18). 
Each protein was labeled with x2~I to high specific activity by the chloramine-T method (19) 
and used, along with caprine anti-Rauscher-MuLV and BALB:virus-2 sera,  to develop appro- 
priate type-specific competition radioimmunoassays. 
Briefly, twofold serial  dilutions of isopycnically purified recombinant viruses were incubated 
at 37°C for 1 h with limiting amounts of caprine hyperimmune antiserum in a 0.2-ml reaction 
mixture containing 10 mM Tris-hydrochloride (pH 7.8), 1 mM EDTA, 0.4% Triton X-100, 1% 
bovine serum albumin, and 20 mM (for p12 and p30 radioimmunoassays) or 250 mM (for p15, 
~10, reverse  transcriptase, and gp70 radioimmunoassays) NaCI.  10  4 cpm of the corresponding 
5I-labeled  viral protein was added and incubated for 3 h at 37°C followed by an overnight 
incubation at 4°C. Saturating amounts of swine anti-goat IgG serum were added, incubated 
for 3 h at 4°C, and diluted with 0.8 ml of the above buffer in which bovine serum albumin was 
omitted.  Immunoprecipitates were collected by centrifugation, supernates aspirated,  and the 
radioactivity in the precipitate measured in a Searle 1285 gamma counter (Searle Radiographics 
Inc., Des Plaines,  Ill.).  Protein concentrations were determined as described by Lowry et  al. 
(2o). 
Results 
In  Vitro Generation of Recombinants between Rauscher-MuL V and BALB:virus-2.  We set 
out to obtain recombinants between a prototype ts mutant of the oncogenic Rauscher 
strain of MuLV (8, 21) and the endogenous xenotropic BALB:virus-2 (9). Use of these 
viruses permitted the design of a  protocol for recombinant virus isolation based upon 
specific virus growth requirements  (Fig.  1).  By assay at  39°C on NIH/3T3  cells,  the 
replication  of the ts mutant  and xenotropic parental  Viruses,  respectively, was effec- 
tively  blocked.  However,  recombinants  possessing  Rauscher-MuLV  envelope  func- 
tions and BALB:virus-2 sequences in genes affected by the ts lesions might be expected 
to grow efficiently in mouse cells at the nonpermissive temperature. 
To generate potential  recombinant  viruses,  we utilized  a  wild  mouse embryo cell 
line, WM-C, which was permissive for replication of certain mouse xenotropic viruses. 
WM-C cells were first chronically infected with BALB:virus-2, and then superinfected 
with  the  Rauscher-MuLV  ts  mutant  at  the  permissive  temperature  (31°C).  The 
mutant  utilized,  ts 25, represented  a  class known to accumulate noncleaved gag gene 
precursors  at  the  nonpermissive  temperature,  39°C  (22).  To  control  for  mutant 
leakiness or reversion, WM-C cells were infected with the mutant alone, and passaged 
under identical conditions. After 4 wk, virus released from each culture was tested for 
infectivity for NIH/3T3  cells at the restrictive temperature.  Only if the infectivity of 
the virus at 39°C was significantly enhanced by passage of the mutant through WM- 
C  cells replicating  the xenotropic virus, were individual  virus clones selected  by the 
microtiter procedure for further analysis  (Fig.  1). 
Table  I  demonstrates  the  results  of  several  experiments  designed  to  generate 
recombinant  viruses.  It can be seen  that  ts  25 was stable,  exhibiting  no evidence of 
infectivity at 39°C after propagation for 4 wk at 31°C in WM-C cells. However, after 
its  passage  in  BALB:virus-2-producing WM-C  cells,  virus  infectivity  for NIH/3T3 
cells at the nonpermissive temperature ranged from 10  o.5 to 1015 polymerase-inducing 
units (PIU)/ml compared to 104"~ 10  ~'° PIU/ml at 3 I°C. Virus growth at 39°C could STUART  A.  AARONSON  AND  MARIANO  BARBACID  469 
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Flo.  1.  Protocol for the in vitro isolation of type-C recombinant viruses between a  ts mutant of 
Rauscher-MuLV and BALB:virus-2. 
TABLE  I 
Frequency of Recombinants between  Rauscher-MuL V ts 25 and BALB.'virus-2 
Virus titer at following temperature: 
Virus source  Percentage of 
Ratio 39°C/  Recombinants*  31°C  39°C  310C 
PIU/ml  % 
WM-C cells 
+  BALB:virus-2  <10  °  <10  °  -- 
+  wt Rauscher-MuLV  105.0  105.0  10  ° 
+  ts 25  105.0  <10  °  <10 -5.0 
m 
WM-C  cells  producing 
BALB:virus-2 +  ts 25 
Exp.  1  104.5  10 ~'°  10  -3.5  0.03 
Exp. 2  105.0  101"5  10  -3.5  0.03 
Exp. 3  104.5  101"5  10  -3.0  0.1 
Exp. 4  104.5  10  °'s  10  -4.o  0.01 
Exponentially growing NIH/3T3 cells were infected at 31°C and 39°C with serial 0.5-1ogre 
dilutions of tissue culture fluids obtained from each virus-infected culture according to the 
protocol depicted in Fig. 1. The virus titer was defined by PIU/ml and was determined by 
the  endpoint  dilution  for  detection  of virion-associated polymerase activity  in  50-fold 
concentrates of tissue culture fluids obtained 3 wk after virus infection. Polymerase activity 
was  measured  by poly(rA).oligo(dT)-directed poly(dT)  synthesis according to  methods 
previously described (10). 
* Maximum frequency of recombinants was determined from the ratio of infectivity at 39°C/ 
31°C. 
have  resulted  from  reversion  of the  mutant  to  wild  type  or  to  complementation  or 
recombination  with  the  xenotropic  virus.  Thus,  assuming  that  all  of  the  viruses 
capable  of propagation  at  the  nonpermissive  temperature  were  true  recombinants, 
the frequency  of recombinants,  as determined  from  the ratio of infectivity at  tba  two 
temperatures,  would  be -0.1%  (Table  I). 
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FXG.  2.  Immunologic  typing  of  the  translational  products  of  rec  25a-3  virus,  a  recombinant 
between Rauscher-MuLV ts25 and BALB:virus-2. Isopycnically purified rec 25a-3 virus was tested 
at twofold serial dilutions as a competing antigen in type-specific radioimmunoassays for Rauscher- 
MuLV (0)  and/or BALB:virus-2 (C)) proteins including: (A)  plS;  (B)  p12;  (C)  p30;  (D)  pl0;  (E) 
reverse transcriptase;  and  (F)  gp70,  In control  experiments, rec 25a-3  virus was tested in  group- 
specific immunoassays (A), in which anti-BALB:virus-2 serum was used to  precipitate  the corre- 
sponding 125I-labeled  Rauscher-MuLV proteins. Protein concentrations were determined according 
to Lowry et al. (20). 
nants have been readily demonstrated in the p 15 and p 12 gag gene-coded proteins, as 
well  as  in  the  reverse  transcriptase  and  envelope  glycoprotein  (gp70)  of mouse 
leukemia viruses (13-15,  17,  18, 23). Furthermore, using appropriate antisera, type- 
specific determinants have also been demonstrated even in the more broadly immu- 
noreactive proteins  such  as  p30  (24)  and  pl0  (M.  Barbacid  and  S.  A.  Aaronson. 
Unpublished observations.). These antigenic determinants have been useful in iden- 
tifying the origin of translational products of in vivo generated recombinants of mouse 
type-C viruses (25, 26). 
To  determine  whether  the  viruses  that  grew  in  NIH/3T3  cells  at  39°C  were 
recombinants,  clonal  viruses were  isolated  from each  potential  recombinant  stock, 
grown up to mass culture, purified by banding in sucrose gradients, and submitted to 
immunologic typing of their translational products. To achieve the greatest range of 
recombinants possible, only a  few virus clones were analyzed from any given experi- 
ment. 
Fig. 2 illustrates the results of analysis of one such virus, rec 25a-3, in type-specific 
radioimmunoassays  for Rauscher-MuLV  and  BALB:virus-2 gag,  pol,  and  env  gene- 
coded  proteins.  In  typing  assays  for  the  p15,  p12  and  p30  structural  proteins  of 
Rauscher-MuLV  (Fig.  2A-C),  the virus exhibited only limited competition. These 
results  demonstrated  the  lack  of immunologic  identity  of the  p15,  p12,  and  p30 
proteins of rec 25a-3 with those of Rauscher-MuLV. In contrast, rec 25a-3 completely 
displaced  the corresponding radioactive probe in each of the homologous radioim- 
munoassays for BALB:virus-2 p15, p12, and p30 gag  gene-coded proteins (Fig. 2A- 
C).  We  have  previously demonstrated  that  only the  inducible  xenotropic class  of 
mouse endogenous viruses, of which BALB:virus-2 is the prototype, fully competes in STUART A. AARONSON AND MARIANO BARBACID  471 
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F[c.  3.  Partial genetic mapping of in vitro generated recombinants between Rauscher-MuLV  ts25 
and BALB:virus-2 induced from their immunologic typing performed as described in Fig. 2 for rec 
25a-3. Proteins exhibiting parental Rauscher-MuLV  (r--n) or BALB:virus-2 (n) antigenic determb 
nants are indicated.  In viruses depicting intracistronic crossing-overs, the relative localization and 
extent  of Rauscher-MuLV  and  BALB:virus-2 derived  genetic  information  has  been  arbitrarily 
assigned. 
these  assays  (25).  Thus,  the  results  shown  in  Fig.  2  establish  the  presence  of the 
BALB:virus-2 gag gene sequences in the rec 25a-3 viral genome. 
We utilized a  similar approach to analyze the envelope glycoprotein of rec 25a-3 
virus.  As  shown  in  Fig.  2F,  Rauscher-MuLV  but  not  BALB:virus-2  type-specific 
determinants were detected in rec 25a-3  gp70.  These results establish rec 25a-3 as a 
recombinant  containing env  gene  sequences  of Rauscher-MuLV  and  at  least  the  5' 
moiety of the gag gene of BALB:virus-2. 
The translational products of rec 25a-3, including the gag gene-coded pl0 protein 
and the reverse transcriptase, were also antigenically typed. Homologous immunoas- 
says  capable  of  detecting  type-specific  determinants  of  these  proteins  were  only 
available  for  the  corresponding  Rauscher-MuLV  products  (16,  17).  As  shown  in 
Figure  2D  and  E,  neither  pl0  nor  reverse  transcriptase  of  rec  25a-3  virus  were 
antigenically homologous with  those of Rauscher-MuLV.  Instead,  they exhibited a 
competition pattern similar to that of BALB:virus-2. These results, along with those 
described above, argue that the sequences coding for the gag and pol gene of rec 25a- 
3  virus  were  derived  from  the  BALB:virus-2 parent,  whereas  its env  gene  product, 
gp70, originated from Rauscher-MuLV. 
We next submitted to immunological analysis 25 clonal viruses isolated according 
to  the  protocol shown  in  Fig.  1.  11  viruses were  demonstrated  to  be  recombinants 
between  Rauscher-MuLV  ts  25  and  BALB:virus-2  (Fig.  3).  The  remainder  were 472  VIRAL GENES INVOLVED IN LEUKEMOGENESIS 
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FIG. 4.  Experimental evidence for intracistronic crossing-overs  in the pol gene of in vitro generated 
recombinants. Isopycnically purified Rauscher-MuLV (0); BALB:virus-2 ((3)); rec 25d-10 (~7); rec 
25c-3 (/X); and rec 25e-8 (A) were tested at twofold serial dilutions as competing antigens in the 
homologous radioimmunoassay for Rauscher-MuLV reverse transcriptase. Protein concentrations 
were determined according to Lowry et al. (20). 
Rauscher-MuLV  revertants  (5)  or phenotypic  mixtures  of the  parental  viruses  (9). 
The origin of the  viral  sequences  of each recombinant  virus was determined  by the 
ability  of its  respective  gene  products  to  compete  in  the  corresponding  Rauscher- 
MuLV  or BALB:virus-2 homologous radioimmunoassays  as described  for rec 25a-3 
virus. 
In some cases,  a  recombinational  event  was mapped within  sequences  coding for 
virion  proteins.  Fig.  4  illustrates  the  competition  pattern  of prototype recombinant 
viruses  in  the  homologous Rauscher-MuLV  reverse-transcriptase  assay.  Rec 25d-10 
competed to a  full  extent,  indicating that  its polymerase originated  from Rauscher- 
MuLV.  In contrast, the competition pattern  of another recombinant,  rec 25c-3, was 
indistinguishable  from  that  of  BALB:virus-2,  suggesting  the  contribution  of  its 
translatable  pol gene sequences  to that  recombinant.  Some  recombinants,  however, 
exhibited  an intermediate  competition pattern.  As shown in Fig. 4, rec 25e-8 reverse 
transcriptase,  although  distinguishable  from that  of Rauscher-MuLV,  more closely 
resembled  it than the BALB:virus-2 enzyme (Fig. 4). These findings were tentatively 
interpreted  as  evidence  for intracistronic  recombination  within  the pol gene  of the 
parental  viruses (Fig. 3). 
The lesion that prevents Rauscher-MuLV ts 25 from replicating at the nonpermis- 
sive temperature has been shown to involve processing of its gag gene-coded precursor 
polypeptide  (22).  From  the  partial  genetic  maps of the  recombinants  generated  by 
this virus and BALB:virus-2 (Fig. 3), it was observed that only one protein, pl0, was 
consistently provided by BALB:virus-2. These results, along with the known location STUART A.  AARONSON AND MARIANO BARBACID  473 
TABLE  II 
Host Range Properties  of Recombinant Viruses Containing Rauscher-MuL V and BALB:virus-2 Genetic 
Sequences 
Viruses  Mouse 
Virus titer on the following assay cells* 
NIH/3T3  BALB/3T3 
Human A673  Canine DI7  Mink MvlLu 
PIU/mI 
Parental viruses 
Rauscher-MuLV  104.6  104.o  < 10  °  < 10  °  < 10  ° 
BALB  :virus-2  < 10  °  < 10  °  102.o  103.0  102.0 
Recombinant 
rec 25a-3  103.5  < 100.5  < 10  °  < 10  °  < 10  ° 
rec 25a-8  10  a'5  < 100.5  < 10  °  < 10  °  < 10  ° 
rec 25b-14  104.5  104.o  <10  °  <10 °  <10  ° 
rec 25c-3  105.0  100.5  <10  °  <10 °  <10 ° 
rec 25c-6  104.0  100.5  < 10  °  < l 0  °  < 10  ° 
rec 25c-14  105.o  <100.5  <10 °  <10 °  <10 ° 
rec 25d-4  104.0  <100.5  <10  °  <10  °  <10  ° 
rec 25d- 10  104.5  <104.0  <10  °  <10  °  <10 ° 
rec 25d-22  104.5  <104"°  <10  °  <10  °  <10  ° 
rec 25d-25  104.o  <103.6  <10  °  <10 °  <10 ° 
rec 25e-8  104.5  104.0  <10  °  <10 °  <10  ° 
* Exponentially growing cultures were infected at serial 0.5-1og~o dilutions with each virus. The virus titer 
in PIU/ml was determined as described  in Table I. 
of sequences  coding for p19  (27),  located  the conditional  defect  of Rauscher-MuLV 
ts 25 at the 3' terminus of its gag gene. 
Host Range Properties of Recombinant Viruses.  Each  recombinant  virus was  analyzed 
for  its  ability  to  infect  and  replicate  in  a  variety  of  assay  cells.  All  11  viruses 
transmitted  at  high  titer  to  NIH/3T3  cells  (Table  II).  Like the  parental  Rauscher- 
MuLV,  five of the recombinants,  rec 25b-14,  rec 25d-10,  rec 25d-22,  rec 25d-25,  and 
rec  25e-8,  also  demonstrated  similar  high  titers  for  infection  of BALB/3T3  cells. 
However, the others showed markedly lower titers in BALB/3T3  than NIH/3T3  cells. 
None of the recombinant  viruses transmitted  to human  (A673)  or canine  (D17)  cell 
lines, known  to be permissive for xenotropic virus replication.  Moreover, their failure 
to  transmit  to  MvlLu  mink  cells  indicated  that  they  lacked  the  host  range  of the 
MCF  virus group  (28)  (Table II). Finally, none of the recombinants  induced morpho- 
logic alteration of permissively infected cells. 
Genetic  Linkage  of  p30  in  Recombinant  Viruses  to  Fv-l-determined  Host  Range 
Restriction.  The  observed  host  range  phenotypes  of the  recombinants  strongly  sug- 
gested patterns of NB- and N-tropism, genetically controlled at the Fv-1 locus (29).  In 
an effort to substantiate  this hypothesis, each recombinant  was analyzed for its ability 
to  propagate  in  embryo  cells  derived  from  several  inbred  strains  with  N-  or  B- 
permissive  alleles  at  Fv-1.  Those  recombinants  that  behaved  like  Rauscher-MuLV 
with  respect  to growth  in  BALB/3T3  and  NIH/3T3  cells also  demonstrated  similar 
titers of infectivity for embryo cells of several N- and B-permissive inbred strains.  The 
infectivity of the remaining recombinants  in N-tropic virus permissive C3H  and CBA 474  VIRAL GENES  INVOLVED  IN  LEUKEMOGENESIS 
TABLE  III 
Genetic Mapping of the Fv-l-determined Host Range Restriction in Recombinant Viruses 
Virus titer on the fol-  Percent comped- 
Virus  lowing assay cell*  Tropism  Origin of Recombi-  tion in the anti- 
nant p30:]:  AKR K36/AKR 
Sim  SimR  MuLV p30 assay§ 
PIU/ml  % 
Rauscher-MuLV  103.o  10  ~'5  NB  100 
KiMuLV  104.5  10 l'°  N  100 
1684  < 10  °  102.5  B  <20 
BALB:virus-2  < 10  °  < 10  °  Xeno  <20 
Recombinants 
rec 25b- 14  103.o  103.5  NB  Rauscher-MuLV  100 
tee 25d-10  103.5  103.5  NB  Rauscher-MuLV  100 
rec 25d~22  103.o  103.o  NB  Rauscher-MuLV  100 
rec 25d-25  103.o  103.5  NB  Rauscher-MuLV  100 
rec 25e-8  104.o  104.o  NB  Rauseher-MuLV  100 
rec 25a-3  10  a'5  101'°  N  BALB:virus-2  <20 
rec 25a-8  10  a'°  <101"°  N  BALB:virus-2  <20 
rec 25c-3  103'6  101"°  N  BALB:virus-2  <20 
rec 25c-6  104.o  101"°  N  BALB:virus-2  <20 
rec 25c- 14  104.0  101'5  N  BALB:virus-2  <20 
rec 25d-4  103"~  10 ''°  N  BALB:virus-2  <20 
* Exponentially growing cultures were infected at serial 0.5-1Oglo dilutions with each virus. Virus titer in 
PIU/ml was determined as described  in the legend to Table I. 
:~ The origin of viral sequences coding for p30 was determined as described  in the legend to Fig. 3. 
§ Relative displacement of the 125I-labeled viral protein achieved by  1 pg of isopycnically  purified virus 
when tested  as competing antigens in the anti AKR-K36 mouse serum:  125I-labeled AKR-MuLV p30 
radioimmunoassay (24). 
embryo cells ranged from  104 to  105 PIU/ml.  Under  the same conditions, these viruses 
titered <102  PIU/ml  in B-permissive C57BL/6  or C57BL/10  cell lines. This pattern 
of  infectivity  was  indistinguishable  from  that  observed  with  Kirsten  MuLV  (Ki- 
MuLV),  a  prototype N-tropic virus. 
As a  final test that  their NB- or N-tropic host ranges were under Fv-1 control, each 
recombinant  virus  was  tested  for  growth  in  embryo  cells of Sim  and  SimR  strains, 
congenic at Fv-1 (4). As shown in Table III, the NB-tropic recombinants demonstrated 
very similar titers for infectivity in Sire and  SimR  cells. In contrast,  each putative N- 
tropic recombinant  virus demonstrated  a  preference for growth  in Sire embryo cells, 
which  possessed  the  N-permissive  allele at  Fv-1. These  findings  established  that  N- 
and  NB-tropic  phenotypes  of the  recombinants  were  under  genetic control  in  Fv-1. 
An  effort  was  next  made  to  correlate  the  presence  of specific  proteins  of either 
parental  virus with host range of the recombinant  virus. As shown  in Table  III, each 
NB-tropic  recombinant  possessed  Rauscher-MuLV  p30  as  determined  by  immuno- 
logic typing  (Fig.  3).  In contrast,  all of the N-tropic  recombinants  contained  BALB: 
virus-2 p30. There was no apparent  correlation between recombinant  virus host range 
and  any other gag, pol, or env gene product  analyzed  (Fig. 3).  Thus,  it was possible to 
assign  the site of Fv- 1 action at or closely linked to the viral p30. 
Recently,  Tress et  al.  (30)  have found  that  antiserum  prepared  in C57BL/6  mice 
against  AKR  K36  leukemia cells (31)  possesses  antibodies  that  specifically recognize STUART A. AARONSON AND MARIANO BARBACID  475 
TABLE IV 
Neutralization of Recombinant Viruses by Normal Mouse Sera 
KiMSV 
pseudotype  Tropism 
Neutralization  titer* of the 
following sera 
C57BL/6  BALB/c 
Parental 
Rauscher-MuLV  NB  <20  <20 
BALB:virus-2  Xeno  2,000  2,000 
Recombinants 
rec 25a-3  N  <20  <20 
rec 25a-8  N  <20  <20 
rec 25c-  14  N  <20  <20 
rec 25d- 10  NB  <20  <20 
rec 25e-8  NB  <20  <20 
D 17-3B3:]:  Xeno  1,000  2,000 
* Neutralization  tests were performed  by the focus reduction  method  (32). 
Around  100  focus-forming units  (flu) of each  helper virus pseudotype  of 
KiMSV were incubated with serial dilutions of normal mouse serum for 30 
min at 37°C before assay on NIH/3T3 or NRK cells. The number of foci 
was scored at 7-10 d. Results are presented as the reciprocal of the highest 
serum dilution giving 67% or greater reduction  in the number of MSV foci. 
:~ D I7-3B3 is a previously described recombinant  between Rauscher-MuLV 
and BALB:virus-2 (25). 
the p30 proteins of MuLV exhibiting either N- or NB-tropic host range. We considered 
it of interest to determine whether the p30 antigenic determinants recognized by anti 
AKR  K36 serum and apparently associated with N-tropism could be detected in the 
N-tropic recombinants,  whose  p30  protein  was  of xenotropic  origin.  Recombinant 
viruses were tested as competing antigens in  the anti-AKR  K36 serum:  125I-labeled 
AKR-MuLV  p30 immunoassay (24). As shown in Table III, none of the recombinants 
possessing BALB:virus-2 p30, in spite of their N-tropic host range, exhibited significant 
competition.  In  contrast,  the  NB-tropic  recombinants,  which  possessed  Rauscher- 
MuLV  p30, scored as positives in the same assay (Table III). These results indicate 
that  the ability of each  recombinant  to compete in  the anti-AKR  K36 serum:  1251- 
labeled AKR-MuLV  p30  was  determined  by the origin of their p30  protein rather 
than by their Fv-1 controlled host range. 
Target of Mouse Serum Neutralizing  Factor for Xenotropic Virus Maps in the env Gene.  It 
has  previously  been  shown  that  sera  of many  mouse  strains  contain  high-titered 
neutralizing activity against xenotropic but  not  ecotropic type-C viruses  (32).  This 
factor  has  been  demonstrated  not  to  have  an  antibody  nature,  but  instead  to  be 
associated with the low-density lipoprotein fraction of normal mouse serum  (33). The 
availability of recombinants  involving Rauscher-MuLV  and  BALB:virus-2 made  it 
possible to map within the viral genome the target of another potent host restriction 
to endogenous virus expression. 
We  compared  the  ability  of  normal  C57BL/6  and  BALB/c  mouse  serum  to 
neutralize the infectivity of KiMSV  pseudotypes of recombinant  viruses containing 
different representations of the genetic sequences of their respective parental viruses. 
As can be seen from the results in Table IV, both sera neutralized the BALB:virus-2 
parental virus at high titer but  had no effect on  the infectivity of Rauscher-MuLV. 476  VIRAL GENES INVOLVED IN LEUKEMOGENESIS 
The infectivity of each of the recombinant viruses involving ts 25 and BALB:virus-2 
was also unimpaired. These viruses varied in their representation of genetic informa- 
tion of the parental viruses, but all encoded the env gene product of Rauscher-MuLV. 
A  previously  characterized  recombinant,  D17-3B3,  was  isolated  from  a  stock  of 
Rauscher-MuLV passaged in BALB/c mice (25).  By typing immunoassays, this virus 
was shown to code for Rauscher-MuLV gag and pol gene products. However, its gp70 
appeared to be a  recombinant  molecule containing  antigenic  determinants  of both 
Rauscher-MuLV  and  BALB:virus-2  origin.  As  shown  in  Table  IV,  D17-3B3  was 
neutralized  by normal  mouse sera  at  the  same high  titers  as  BALB:virus-2.  These 
results help to identify the env gene as the region within the xenotropic viral genome 
coding for the target of the neutralizing factor. 
Discussion 
This  report  describes  an  approach  to  mammalian  type-C  virus  genetic  analysis 
involving the  generation  of recombinant  viruses  in  tissue  culture.  We  have  taken 
advantage  of  the  temperature  restriction  of  a  Rauscher-MuLV  mutant  and  the 
xenotropic  host  range  of an  endogenous  mouse  type-C  virus  to  devise  a  double 
selection system for isolation of recombinant viruses. This has allowed the reproducible 
isolation of relatively large numbers of recombinants from parental viruses with very 
different biological properties. Furthermore, the fact that one of the parentals was a 
conditional  mutant,  potentially  allows  recombinants  to be designed  in  almost  any 
viral gene for which there exists a ts lesion. 
In this  study,  we utilized  Rauscher-MuLV  ts  25,  a  mutant  blocked  in gag  gene 
precursor polypeptide cleavage (22).  All of the recombinants obtained were shown to 
replace, at least, the p 10 protein of this virus with that of BALB:virus-2, thus mapping 
the lesion in ts 25 at the carboxy terminus of the viral gag gene (27). The inhibition 
of gag  gene  precursor  polypeptide  processing by a  ts  lesion  located  at  its  carboxy 
terminus could be interpreted as evidence for the existence of potarity in its maturation 
process. Alternatively, the ts lesion could cause an alteration of the tertiary structure 
of this polyprotein in such a way that normal processing is impaired. 
The genomes of the recombinant  viruses isolated in this study have been charac- 
terized by immunologic typing of the antigenic determinants present  in their trans- 
lational products  (25).  This allows the identification of most type-C viral proteins as 
belonging to a specific parent. Thus, we were able to unambiguously identify viruses 
as recombinants and construct a  partial genetic map of their respective genomes. By 
this approach, it was possible to demonstrate frequent crossing-overs in many individ- 
ual  recombinants. Oligonucleotide  fingerprinting  analysis of avian type-C recombi- 
nant viruses have indicated that viable recombinants require the presence of sequences 
of the same parental  virus at both  5' and  3' termini  (34).  If this were the case, the 
number  of crossing-overs would  range  from  two  to  as  many  as  four  among  the 
different  mouse type-C virus recombinants isolated  in this study.  The frequency of 
recombination was also determined,  Frequencies ranged from 0.01  to 0.05%, at least 
100-fold lower than those reported with avian type-C viruses (35, 36). These differences 
may be a  result of the fact that the genomes of the parental avian viruses are much 
more closely related than those of the mouse type-C viruses utilized in our studies. 
The  Fv-1  locus  is  an  important  genetic  restriction  that  affects endogenous  virus 
expression  and  neoplasia  (29).  Intensive  efforts  to  study  the  mechanism  of  Fv-1 STUART  A.  AARONSON AND  MARIANO  BARBACID  477 
restriction  have led to understanding  that  it involves an intracellular  block to virus 
replication and is exerted at a  level before virus integration  (37,  38).  Many Fv-1 B- 
permissive mouse strains contain N-tropic endogenous viruses. The late appearance of 
B-tropic virus is often associated with the development of lymphoma (39).  There is 
strong  evidence  that  the  B-tropic  virus  arises  as  a  result  of genetic  alteration  or 
recombination  involving the N-tropic virus rather than  from a  distinct  endogenous 
virus  (26,  40, 41).  Genetic as well as biochemical and immunological evidence have 
linked  the Fv-1  gene restriction  with  the region  of the viral genome coding for the 
major structural protein p30 (30,  42-45). 
In  our  studies,  analysis  of the  host  range  of a  large  group  of mouse  cell-tropic 
recombinants between  the  NB-tropic Rauscher-MuLV  and xenotropic parental  vi- 
ruses revealed the acquisition of a  host range phenotype distinct  from that of either 
parent.  Many  recombinants  exhibited  N-tropic  host  range  as  defined  not  only by 
growth  in  NIH/Swiss and  BALB/c cells but  in other mouse strains,  including  Sire 
and SimR, congenic at Fv-1  (4).  Our results demonstrated that preservation of NB- 
tropism by the recombinant was correlated with conservation of Rauscher-MuLV p30 
and  with  no  other  known  virus  coded  gene  product.  Thus,  these  findings  further 
establish a  target of Fv-1  restriction  at or very near viral sequences coding for p30. 
Previous studies have demonstrated  a  very close immunologic relationship  between 
the  respective gag  gene  products  of N-tropic  and  inducible  xenotropic endogenous 
type-C viruses. These findings have suggested that the latter arose by recombination 
from the ecotropic virus relatively recently in evolution (25). The fact that the BALB: 
virus-2 gag  gene p30 confers N-tropic host  range to recombinant  viruses capable of 
infecting mouse cells is evidence consistent with this concept. 
A  potent  inhibitor  of xenotropic  virus  expression  in  many  mouse  strains  is  a 
neutralizing  factor  (32)  that  resides  within  the  low-density  lipoprotein  fraction  of 
normal mouse serum (33). The mechanism of action of this factor is not yet understood. 
It was possible to demonstrate lack of neutralization  by mouse serum of any of our 
newly  generated  recombinants,  each  of which  shared  only  presence  of sequences 
coding for Rauscher-MuLV gp70. Conversely, a previously isolated in vivo recombi- 
nant, in which a  large portion of the Rauscher-MuLV env gene has been substituted 
by BALB:virus-2 sequences (25) was as effectively neutralized by mouse serum as the 
parental xenotropic virus. Thus, the site of action of this host control on xenotropic 
virus expression was demonstrated to map at the viral env gene. 
Among the most important biologic questions pertaining to replication-competent 
type-C viruses concerns the mechanism by which they cause neoplasia. Recombinants 
generated  and  characterized  in  this  report  should  be  useful  in  determining  what 
regions of the viral genome are essential for oncogenicity. In addition, such recombi- 
nants  made it possible to determine whether endogenous xenotropic viruses possess 
malignant  potential.  In either case, in  vivo testing of the oncogenic properties of a 
wide range of recombinants constructed as described in these studies should provide 
a  useful strategy that may eventually allow localization of the putative "leuk" gene 
of the leukemia virus. 
Summary 
An  approach  toward  elucidation  of  the  mechanisms  of action  of  mammalian 
leukemia viruses has been made by the generation  in  tissue culture of recombinant 478  VIRAL GENES  INVOLVED IN LEUKEMOGENESIS 
viruses between a  potent murine leukemia virus (MuLV),  Rauscher-MuLV,  and an 
endogenous xenotropic mouse type-C virus, BALB:virus-2, without known malignant 
potential. Using a  double selection system devised to select against the temperature- 
sensitive (ts) lesion associated with a  mutant of Rauscher-MuLV and the xenotropic 
host range of BALB:virus-2, recombinant viruses were obtained at frequencies ranging 
from  0.01  to  0.1%.  Recombinant  viruses  were  identified  on  the  basis  of the  type 
specific antigenic determinants  in  the translational products of gag  (p15,  p12,  p30, 
and  pl0 proteins), pol  (reverse transcriptase), and env  (gp70 glycoprotein) genes.  By 
this  approach,  the  partial  genetic  maps  of a  large  number  of recombinants  were 
obtained. The  fact that  pl0 of Rauscher-MuLV  ts 25, the mutant  utilized, was the 
only protein uniformly lacking in recombinant viruses, localized the lesion inhibiting 
gag precursor cleavage in this mutant at the carboxy terminus of its gag gene. 
The  recombinant  viruses demonstrated  two  host  range phenotypes as defined by 
Fv-1 host cell restriction. In each case, NB-tropic recombinants possessed the p30 of 
the  Rauscher-MuLV  parent,  whereas  the  rest,  N-tropic  in  host  range,  exhibited 
BALB:virus-2 p30. Thus, it was possible to assign the site of Fv-1 action at, or closely 
linked, to the viral p30. The target within the viral genome of a second host restriction 
was  also mapped.  A  serum  factor, previously shown  to specifically inactivate xeno- 
tropic  virus  infectivity, was  demonstrated  to  exert  its  action  on  the  viral  env  gene 
product.  The  system  described  here  allows the  generation  of specific recombinant 
genotypes that should be useful in defining those regions of the viral genome involved 
in leukemogenesis. 
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